303 related articles for article (PubMed ID: 17094140)
1. Evaluation of the Texas Birth Defects Registry: an active surveillance system.
Miller E
Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):787-92. PubMed ID: 17094140
[TBL] [Abstract][Full Text] [Related]
2. Registry to referral: using birth defects registries to refer infants and toddlers for early intervention services.
Farel AM; Meyer RE; Hicken M; Edmonds LD
Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):647-50. PubMed ID: 14703788
[TBL] [Abstract][Full Text] [Related]
3. Methodological issues in setting up a surveillance system for birth defects in India.
Suresh S; Thangavel G; Sujatha J; Indrani S
Natl Med J India; 2005; 18(5):259-62. PubMed ID: 16433142
[TBL] [Abstract][Full Text] [Related]
4. Developing a database management system to support birth defects surveillance in Florida.
Salemi JL; Hauser KW; Tanner JP; Sampat D; Correia JA; Watkins SM; Kirby RS
J Registry Manag; 2010; 37(1):10-5; quiz 38-9. PubMed ID: 20795564
[TBL] [Abstract][Full Text] [Related]
5. The Department of Defense Birth Defects Registry: overview of a new surveillance system.
Ryan MA; Pershyn-Kisor MA; Honner WK; Smith TC; Reed RJ; Gray GC
Teratology; 2001; 64 Suppl 1():S26-9. PubMed ID: 11745841
[TBL] [Abstract][Full Text] [Related]
6. Development of a web-based integrated birth defects surveillance system in New York State.
Wang Y; Tao Z; Cross PK; Le LH; Steen PM; Babcock GD; Druschel CM; Hwang SA
J Public Health Manag Pract; 2008; 14(6):E1-E10. PubMed ID: 18849767
[TBL] [Abstract][Full Text] [Related]
7. Improving case ascertainment of a population-based birth defects registry in New York State using hospital discharge data.
Wang Y; Sharpe-Stimac M; Cross PK; Druschel CM; Hwang SA
Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):663-8. PubMed ID: 16240383
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation on birth defects surveillance system in four counties of Shanxi province, China].
Li ZW; Ren AG; Zhang L; Zhu JH; Zhang YW; Yue YH; Liu XW; Gong JP; Li Y; Li Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Mar; 27(3):208-11. PubMed ID: 16792885
[TBL] [Abstract][Full Text] [Related]
9. Clinician reviewers in birth defects surveillance programs: survey of the National Birth Defects Prevention Network.
Lin AE; Forrester MB; Cunniff C; Higgins CA; Anderka M
Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):781-6. PubMed ID: 17051528
[TBL] [Abstract][Full Text] [Related]
10. National rates of birth defects among hospitalized newborns.
Bird TM; Hobbs CA; Cleves MA; Tilford JM; Robbins JM
Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):762-9. PubMed ID: 17063529
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of using the national hospital discharge survey to estimate the prevalence of selected birth defects.
Boulet SL; Correa-Villaseñor A; Hsia J; Atrash H
Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):757-61. PubMed ID: 17094134
[TBL] [Abstract][Full Text] [Related]
12. Impact of including elective pregnancy terminations before 20 weeks gestation on birth defect rates.
Ethen MK; Canfield MA
Teratology; 2002; 66 Suppl 1():S32-5. PubMed ID: 12239742
[TBL] [Abstract][Full Text] [Related]
13. Process of and problems in changing a birth defects registry reporting system.
Druschel C; Sharpe-Stimac M; Cross P
Teratology; 2001; 64 Suppl 1():S30-6. PubMed ID: 11745842
[TBL] [Abstract][Full Text] [Related]
14. Pilot test of prenatal surveillance for birth defects in South Texas.
Ethen MK; Canfield MA; Trevino J
Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):788-91. PubMed ID: 17990339
[TBL] [Abstract][Full Text] [Related]
15. Hospital discharge data: can it serve as the sole source of case ascertainment for population-based birth defects surveillance programs?
Wang Y; Cross PK; Druschel CM
J Public Health Manag Pract; 2010; 16(3):245-51. PubMed ID: 20357611
[TBL] [Abstract][Full Text] [Related]
16. Estimating prevalence of fetal alcohol syndrome (FAS): effectiveness of a passive birth defects registry system.
Fox DJ; Druschel CM
Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):604-8. PubMed ID: 14703781
[TBL] [Abstract][Full Text] [Related]
17. Random error and undercounting in birth defects surveillance data: implications for inference.
Correa-Villaseñor A; Satten GA; Rolka H; Langlois P; Devine O
Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):610-6. PubMed ID: 14703782
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of selected characteristics of pregnancy drug registries.
Honein MA; Paulozzi LJ; Cragan JD; Correa A
Teratology; 1999 Dec; 60(6):356-64. PubMed ID: 10590397
[TBL] [Abstract][Full Text] [Related]
19. Using active birth defects surveillance programs to supplement data on fetal death reports: improving surveillance data on stillbirths.
Duke W; Williams L; Correa A
Birth Defects Res A Clin Mol Teratol; 2008 Nov; 82(11):799-804. PubMed ID: 18985684
[TBL] [Abstract][Full Text] [Related]
20. Measurements of birth defect prevalence: which is most useful as a comparator group for pharmaceutical pregnancy registries?
Scheuerle A; Vannappagari VX; Miller MK
Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):611-20. PubMed ID: 19215016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
